pCLC-mEos2
(Plasmid
#38010)
-
Depositing Lab
-
Depositing OrganizationHarvard University
Located in United States of America -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 38010 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
| DNA | 38010-D50 | 50 μg of DNA in Tris buffer | $495 | ||
| DNA | 38010-D100 | 100 μg of DNA in Tris buffer | $585 | ||
Backbone
-
Vector backbonepEYFP-N1
-
Backbone manufacturerClontech
- Backbone size w/o insert (bp) 4700
- Total vector size (bp) 5340
-
Modifications to backboneEYFP sequence removed with AgeI (5') and NotI (3'). Replaced with mEos2.
-
Vector typeMammalian Expression, Bacterial Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameClathrin, light polypeptide (LCa)
-
Alt nameClta
-
SpeciesM. musculus (mouse)
-
Insert Size (bp)657
-
GenBank IDNM_001080385
-
Entrez GeneClta (a.k.a. Lca)
- Promoter CMV
-
Tag
/ Fusion Protein
- mEos2 (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site KpnI (not destroyed)
- 3′ cloning site AgeI (not destroyed)
- 5′ sequencing primer CMV promoter
- (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made bymEos2 was originally a kind gift of Dr. Michael W. Davidson (Florida State University) and Dr. Loren L. Looger (Howards Hughes Medical Institute, Janelia Farm). Clathrin light chain was a kind of gift of Dr. James H. Keen (Kimmel Cancer Center).
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Note: The clathrin light chain has an A9D amino acid residue substitution. This is a natural variant that does not affect protein function.
DNA (Catalog # 38010-D50)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 50 μg
- Concentration 1 μg/μL
- Pricing $495 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
DNA (Catalog # 38010-D100)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 100 μg
- Concentration 1 μg/μL
- Pricing $585 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCLC-mEos2 was a gift from Xiaowei Zhuang (Addgene plasmid # 38010 ; http://n2t.net/addgene:38010 ; RRID:Addgene_38010) -
For your References section:
Fast, three-dimensional super-resolution imaging of live cells. Jones SA, Shim SH, He J, Zhuang X. Nat Methods. 2011 Jun;8(6):499-508. Epub 2011 May 8. 10.1038/nmeth.1605 PubMed 21552254